Gene set enrichment analysis indicated that SNX1 downregulation is linked to activation of cancer-related pathways, including p53 signaling, PI3K/AKT signaling, and cell cycle–associated programs such as E2F targets and G2/M checkpoint. The gene discussed is SNX1; the disease is cancer.